Sunday, February 07, 2016 8:31:15 PM
CBS NEWS February 7, 2016, 11:54 AM
After a week of reporting from "ground zero" of the Zika virus outbreak in Brazil, CBS News chief medical correspondent Dr. Jon LaPook says no amount of background reading or medical research could have prepared him for seeing the emotional toll this illness has taken on families there. Zika is blamed for a spike in the number of babies born with abnormally small heads, a birth defect called microcephaly, which is often accompanied by mental retardation.
"When you actually look for the first time into the eyes of parents whose baby has microcephaly, and of course, when you look at the baby who has microcephaly, it just takes your breath away," LaPook said.
In the video above, he spoke with freelance producer/interpreter Kate Steiker-Ginzberg about the experience of covering this developing crisis in Brazil, starting with a visit to the Oswaldo Cruz University Hospital in Recife, which has seen more cases of microcephaly than anywhere else.
24 PHOTOS
Zika virus takes heartbreaking toll
"Seeing babies with microcephaly was very emotional," he said. "It's devastating for [the families]. They don't know what the future holds. And of course every mother loves their baby and wants to protect it ... It was so touching to me ... The mothers said, 'This is my baby, I'm going to love my baby for the rest of his life. But what's everybody else going to do? What's society going to do?' There's this stigma in Brazil."
Doctors in Recife were instrumental in identifying the growing problem last fall, when dozens of mothers started bringing in babies with what had been, up until then, a very rare birth defect.
LaPook and his team also interviewed researchers a a leading laboratory working on unraveling the mysteries of Zika virus and how it spreads. Understanding of the virus has been changing rapidly with each new discovery. In recent days, scientists reported that in addition to being spread by mosquitoes -- by far the most common means of transmission -- a small number of cases have occurred of Zika being spread through sex and through blood transfusions. They also detected evidence that the virus can be found in saliva samples.
"And of course, each one of these is followed up by a lot of questions. What does that mean? Can you actually get it from kissing somebody, with saliva? From what we know, and Dr. Anthony Fauci, who's the head of infectious diseases for the NIH told me, just because you have virus in the saliva doesn't mean that you can give it to somebody that way. I think that's a very important thing," LaPook said.
As global travel makes the world "a smaller and smaller place," viruses can spread more widely than ever before, requiring greater efforts to control emerging threatslike Zika and other tropical illnesses like dengue and chikungunya. LaPook believes this will require a whole new approach.
"We've been doing a 'whack-a-mole' where something pops up and we treat that," he said. "We have to think differently, we have to do almost an effort like when we said we're going to the moon -- a moonshot effort ... How can we set up a way so that we can confront other viruses, because you know there's going to be another virus. Maybe it's a whole different way of thinking about making vaccines, of treatment."
Click on the link for a video.
cbsnews.com
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
- NanoViricides, Inc. to Present at The Inaugural Ef Hutton Global Conference on May 10, 2023 in New York City • GlobeNewswire Inc. • 05/04/2023 10:45:00 AM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM